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Language development builds upon a complex network of interacting subservient systems. It
therefore follows that variations in, and subclinical disruptions of, these systems may have
secondary effects on emergent language. In this paper, we consider the relationship between
genetic variants, hearing, auditory processing and language development. We employ whole
genome sequencing in a discovery family to target association and gene x environment
interaction analyses in two large population cohorts; the Avon Longitudinal Study of Parents
and Children (ALSPAC) and UK10K. These investigations indicate that USH2A variants are
associated with altered low-frequency sound perception which, in turn, increases the risk of
developmental language disorder. We further show that Ush2a heterozygote mice have low-
level hearing impairments, persistent higher-order acoustic processing deficits and altered
vocalizations. These findings provide new insights into the complexity of genetic mechanisms
serving language development and disorders and the relationships between developmental
auditory and neural systems.
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Learning to use and understand language requires the coor-dinated development of a whole host of underlying skills andprocesses. Assuming an initial bottom-up framework as
posited by Tallal & others1, the first step in typical language
development requires hearing, which allows infants to identify
and parse meaningful signals from background noise and envir-
onmental distractors (auditory perception). These sounds are
then mapped onto speech units (phonemes) enabling the
extraction of meaningful linguistic constructs (comprehension).
Even newborn babies turn their heads towards familiar voices and
show a preference for speech over white noise2. These inclina-
tions are fined-tuned over early life such that, at 3 months, infants
show a preference for their native tongue over foreign languages
and other vocal sounds (e.g. laughter)3. These behavioural dis-
tinctions are mirrored at the cognitive level; many studies show
that speech evokes distinct neural responses, indicating that
language is subject to privileged processing4. Early speech pro-
cessing skills correlate with later language milestones5 suggesting
that they modulate successful language acquisition.
While hearing is not strictly essential to successful language
development (see ref. 6), overt disturbance of the contributory
processes can directly disrupt language development; congenital
hearing loss is associated with widespread cognitive deficits in
domains including attention, memory and language7. Less
obvious disturbances of audition can also indirectly impact spo-
ken language development, especially if they occur during critical
time periods or in addition to other insults. For example, auditory
processing disorder (APD), characterized by poor central sound
processing despite apparently normal hearing, can lead to diffi-
culties understanding speech in noisy environments8 and, when
persistent, is associated with an increased risk of Developmental
Language Disorder (DLD) and Attention Deficit, Hyperactivity
Disorder (ADHD)9. In the current study we test this framework
by assessing whether typical variations across genes that function
in auditory pathways may form part of a complex risk mechanism
in the emergence of language disorders. In support of our pro-
posed framework, subtle disturbances of auditory processing have
been described across many neurodevelopmental disorders where
hearing is unaffected (e.g. autistic disorder (as reviewed by ref. 10,
ADHD11 and dyslexia12). Similarly, declines in later-life auditory
processing skills are correlated with altered language function13.
The observed overlaps and comorbidities between neurodeve-
lopmental and language disorders illustrate the complexities of
contributory networks and the inter-reliance of developmental
psychopathologies. In the long-term, all of these disorders are
associated with academic limitation and reduced quality of life8,14
and represent an economic burden upon health-care and edu-
cation systems15.
Although APD and DLD are both common childhood condi-
tions (as high as 10%)16,17, our understanding of the relationships
between hearing, auditory processing and language are con-
founded by these comorbidities alongside a lack of consistent
diagnostic guidelines and failure to identify causal mechanisms18.
As for many neurodevelopmental disorders, genetic contributions
are poorly understood6,19. While monogenic forms of language
disorder have been identified20, the majority of genetic risk fac-
tors are expected to function within complex models where each
variant has only a small effect size and is influenced by additional
genetic and environmental interactors19. Genome-wide screens
indicate that large sample sets will be required to map variants
that contribute to language disorder21 and acquisition22 and
recent studies indicate shared genetic effects across behavioural
subsets and between disorder and typical development19.
Current research suggests that genetic effects can overlap
between syndromes that have traditionally been considered as
clinically distinct. Similarly, genetic overlaps are reported between
Mendelian forms of disease and more complex forms of dis-
order23–25. These changes in the field led us to apply an alter-
native approach to the investigation of molecular mechanisms
underlying hearing and language within the current study. More
specifically, we investigate the molecular overlaps between hear-
ing, auditory processing and language through the targeted study
of a gene that has an established role in audition—USH2A. This
gene encodes the Usherin protein, which acts as a lateral link
between stereocilium, providing structural organization for hair
cell bundle development26. Homozygous pathogenic changes in
USH2A, and therefore complete absence of the usherin protein,
result in disorganization or loss of cochlear outer hair cells27,
leading to congenital hearing loss clinically described as Usher
Syndrome (OMIM#276901)28,29. This syndrome is a monogenic
recessive disorder (4 in 100,000 births) associated with hearing
loss specific to the high-frequency ranges, often accompanied by
retinitis pigmentosa. The disorder splits into three clinical cate-
gories (Types I–III), relating to severity and age of onset28,30 and
homozygous USH2A mutations result in the majority of Type-II
cases in which diagnosed individuals are born with hearing loss
and develop retinitis pigmentosa at the onset of puberty, yet do
not experience the vestibular dysfunction (i.e. difficulties with
balance and coordination) found in other types of Usher31. In
accordance with currently accepted genetic models, individuals
with a heterozygous USH2A mutations are considered to be
unaffected carriers.
In the current study, we employ whole-genome sequencing in a
discovery family to target association and gene x environment
interaction analyses in two large population cohorts; the Avon
Longitudinal Study of Parents and Children (ALSPAC) and
UK10K. We complement these statistical methodologies with the
characterization of a mouse model that shows behavioural effects
of a heterozygous knockout on hearing, complex acoustic pro-
cessing, and communicative vocalization. We propose the exis-
tence of an “alleleic hierarchy” of variation within which different
variant types have divergent effects upon auditory thresholds. We
show that USH2A variants exert direct effects upon low-
frequency hearing and indirectly affect the risk of language dis-
order through the modulation of subsequent auditory perception
and language development. These findings suggest a shared
genetic etiology between hearing mechanisms, central auditory
processing and language development and support the targeted
investigation of sub-serving mechanisms in relation to language
development.
Results
AnUSH2A variant cosegregates with language disorder. A
multi-generational family was ascertained for genetic investiga-
tion (Fig. 1). The family included seven Non-Founder individuals,
all of whom were affected by a severe expressive language dis-
order. Affected individuals presented with slow and dysfluent
speech and difficulties characteristic of APD, namely processing
speech and following instructions, particularly in the presence of
background noise or absence of visual cues (e.g. on the phone).
The proband (IV.I, Fig. 1) and her sister (IV.2, Fig. 1) attended a
special school for children with speech and language difficulties.
Hearing assessments in the proband and sister were normal.
Pure-tone audiometry tests in the Grandfather (II.I, Fig. 1)
indicated normal hearing thresholds but deficits were noted
across three tests of central auditory processing (dichotic digits,
frequency pattern and duration pattern). Further details of the
phenotype are provided in the Methods. Genome sequencing of
two individuals (II.2 and IV.1) identified a novel stop-gain
mutation (a change which results in a truncated protein) in the
USH2A gene (NP_996816:p.Gln4541*) shared by all affected
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family members (Fig. 1, Supplementary Dataset 1). This variant
(rs765476745) has previously been documented in cases of Usher
syndrome and retinitis pigmentosa in whom it was documented
to occur with a secondary pathogenic variant in a compound
heterozygote mechanism32–34. The hearing of heterozygotes was
not assessed within these previous studies32–34. rs765476745 has a
Combined Annotation Dependent Depletion (CADD) score of
40, placing it in the top 0.01% of deleterious variants in the
genome35, and meets clinical guidelines from the American
College of Medical Genetics (ACMG) for a “pathogenic var-
iant”36; it confers a stop mutation (Very strong evidence of
pathogenicity—PVS1), has previously been described as patho-
genic (Strong evidence of pathogenicity—PS1), is absent from
population databases (Moderate evidence of pathogenicity—
PM2) and cosegregates with disease (Supporting evidence of
pathogenicity—PP1)36. No secondary putative pathogenic chan-
ges were found in other genes related to Usher syndrome or
hearing loss (Supplementary Dataset 1). Given the inheritance
pattern and complete cosegregation, in the absence of a second
pathogenic variant, we hypothesized that the observed hetero-
zygous loss of USH2A could account for the observed language
disorder in this family.
Heterozygous Ush2a KOs have altered auditory perception. To
elucidate the behavioural effects of heterozygous Ush2a loss, we
generated heterozygous (HT) and full knockout (KO) mice.
Hearing and complex acoustic discrimination thresholds were
compared against WT controls on a series of prepulse inhibition
(PPI) tasks37. Initially, using a simple single-tone detection task at
40 kHz (high-frequency), individual ANOVAs revealed that KO
mice trended to the expected hearing impairment typical of Usher
syndrome, while HT mice performed similarly to WT controls
[(Overall): F(2,32)= 1.995, p= 0.153, one-tail; (WT vs. HT): F(1,
22)= 0.619, p= 0.440; (WT vs. KO): F(1, 21)= 3.125, p= 0.092;
(HT vs. KO): F(1, 21)= 1.517, p= 0.232 (Fig. 2a). In contrast,
using this same task at 15 kHz (low-frequency), HT mice per-
formed significantly worse than KOs and trended to worse than
WTs [(Overall): F(2,32)= 3.697, p= 0.36; (WT vs. HT): F(1, 22)
= 3.201, p= 0.087; (WT vs. KO): F(1, 21)= 1.054, p= 0.316;
(HT vs. KO): F(1, 21)= 5.016, p= 0.036], while WT and KO did
not differ (Fig. 2a). In order to assess possible higher-order
processing deficits, individual scores on the above single-tone task
were used as covariates (frequency-matched) to analyze more
complex PPI measures (thus eliminating variance due to hearing
impairments). In repeated measures ANCOVAs with Genotype
as the between-subjects variable and Day and Cue as the within-
subject variables, deficits were again evident for HT mice on
complex low-frequency tasks [Embedded Tone 100: 10.5 kHz: F
(2, 31)= 3.691, p= 0.036; Embedded Tone 10: 10.5 kHz: F(2, 31)
= 4.635, p= 0.017)], and for KO mice on higher frequency tasks
[Pitch Discrimination: 40.5 kHz (WT vs. KO); F(1, 20)= 9.232, p
= 0.006] (Fig. 2b–d). These findings indicate that Ush2a-medi-
ated perceptual deficits include higher-order dysfunction, even
when variance due to hearing loss was removed.
Heterozygous Ush2a KOs have altered vocalizations. Given the
reported comorbidity between auditory processing and language
impairments and the presence of dysarthria in the discovery
family, we investigated whether Ush2a knockout in mice altered
the properties of their ultrasonic vocalizations. Results showed
that Ush2a HT mice vocalized at significantly higher frequencies
(pitch) across most syllable types [F(2, 16100)= 83.476, p=
0.000] and produced calls that were shorter and louder than WTs
[duration: F(2, 16100)= 26.70, p= 0.000; volume: F(2, 16100)=
142.54, p= 0.000] (Fig. 3). (See Supplementary Fig. 1 for images
and coding technology for eight primary call types assessed).
Interestingly, Ush2a KO mice also produced higher pitched calls
suggesting that disruption to auditory processing ability
(regardless of the frequency of the stimuli) results in impaired
expressive communication ability. This could reflect the impor-
tance of intact auditory feedback for vocal development (e.g.
anomalous song production in deafened birds), and is consistent
with the higher vocal pitch observed in in profoundly deaf
speakers38. The putative social impact of any vocalization
I.1                     I.2
II.3                           II.1                     II.4            II.2
III.1            III.2                   III.3                    III.4
IV.1                  IV.2
II.1 - Affected heterozygous carrier
chr1:215847632, GA (hg19)
III.3 - Affected heterozygous carrier
chr1:215847632, GA (hg19)
IV.1- Affected heterozygous carrier
chr1:215847632, GA (hg19)
IV.2- Affected heterozygous carrier
chr1:215847632, GA (hg19)
III.4 - Unaffected homozygous reference
chr1:215847632, GG (hg19)
II.2 - Affected heterozygous carrier
chr1:215847632, GA (hg19)
Fig. 1 Discovery Family and cosegregation of USH2A variant. Individuals affected by APD are coloured in black. Unaffected individuals are shown in white.
Line through symbol indicates that individual is deceased. All descendants of individual I.1 were affected by a severe expressive language disorder. The only
unaffected individuals in the family were incoming Founder members (I.2, II.2, II.3, III.4). Chromatograms show validation of USH2A variant in wider family
members. The variant (position indicated by a blue highlight bar) was observed in a heterozygous form in all affected individuals.
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Fig. 2 Ush2a HT mice show low-frequency auditory impairments. Relative performance on various prepulse inhibition paradigms (lower scores equal
better performance). a Normal Single Tone at 15 kHz and 40 kHz displayed. b Embedded Tone 0-100 at 10.5 kHz analyzed across days using NST 15 kHz as
a covariate. c Embedded Tone 0-10 at 10.5 kHz analyzed across days using NST 15 kHz as a covariate. d Pitch Discrimination at 40 kHz analyzed across
days using NST 40 kHz as covariate. Data shown are mean ± SEM for each Genotype. *p < 0.05; #p < 0.15. White diamond indicates Genotype mean. All
panels included 35 biologically independent animals (12 WT, 12 HT, 11 KO). Data underlying these figures are provided in Supplementary Dataset 3.
Fig. 3 Ush2a HT mice produce altered ultrasonic vocalizations (USVs). a Syllable Frequency per Genotype collapsed across syllable category. b Syllable
Duration per Genotype collapsed across syllable category. c Syllable Volume per Genotype collapsed across syllable category. Data shown are mean ± SEM
for each Genotype. ***p < 0.001. White diamond indicates Genotype mean. All panels included 34 biologically independent animals (12 WT, 11 HT, 11 KO).
Data underlying these figures are provided in Supplementary Dataset 4.
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anomalies will require additional study. Our behavioural inves-
tigations of the mouse model indicate that heterozygous disrup-
tion of Ush2a leads to altered low-frequency hearing thresholds, a
phenotype distinct from the high-frequency hearing loss of Usher
syndrome (and replicated in null Ush2a mice). Moreover, these
altered low-frequency thresholds were further associated with
higher-order auditory processing deficits, as well as disrupted
vocalizations.
Pathogenic USH2A carriers recapitulate the mouse model. The
description of a single case family does not warrant a claim of
causation, even when supported by an animal model. We there-
fore sought to characterize the developmental profiles of other
individuals with heterozygous USH2A knockout. The effects of
pathogenic USH2A variants were explored through the investi-
gation of developmental profiles of UK10K children39. Fourteen
UK10K individuals (12M:2 F, from 1646 individuals with
sequence and phenotypic data available, 0.85%, Table 1) were
identified as carriers of USH2A changes that were designated as
“pathogenic” in ClinVar. These consisted of five distinct variants
which were always detected in a heterozygous form (Table 1). The
variant found in the discovery family (rs765476745) was not
present in the UK10K samples (Table 1). Analyses of develop-
mental behavioural data showed that USH2A carriers scored
below expected on measures of early vocabulary (Cohen’s d=
0.7237, 95% CI= 0.18–1.27) and word combinations (Cohen’s d
= 1.09, 95% CI= 0.54–1.63) (Table 2). Parents of carriers were
twice as likely to be concerned about their child’s speech at 3
years of age (RR= 2.07, 95% CI= 0.57–7.49) and reported a
higher incidence of stuttering (RR= 2.92, 95% CI= 1.05–8.08)
and dyslexia (RR= 1.88, 95% CI= 0.28–12.45) at age 8 (Table 3).
In support of our mouse model, we also observed a low-
frequency-specific hearing phenotype in heterozygous indivi-
duals; carriers had average low-frequency (500 Hz) hearing
thresholds 1.2 dB HL above those of non-carriers (Table 2) but
did not display overt hearing loss (Table 3) or differences at
higher frequencies (Table 2). Thus across mouse and human data,
we find evidence that heterozygous USH2A variants affect higher-
order auditory processing and increase the risk of delayed lan-
guage milestones. In line with current literature, these variants
alone do not result in a discernible carrier phenotype (as would be
expected in a monogenic model)40. Instead, we propose that they
form part of a genetic risk factor within a complex genetic model.
USH2A variants are associated with low-frequency hearing.
Targeted association analyses were performed to investigate the
wider effects of USH2A polymorphisms on hearing and language
within typical development. SNPs tagging common USH2A var-
iants were analysed for allelic association in the ALSPAC cohort41
(N= 7691 individuals, N= 127 variants). Three measures of
language (early vocabulary size (vocab), nonword repetition
(NWR) and developmental language disorder (DLD) status), and
two hearing measures (low-frequency hearing (minimum air
conduction threshold at 0.5 kHz; MinLow) and mid-frequency
hearing (minimum air conduction threshold at 1, 2 and 4 kHz;
MinMid)) were assessed. In support of the carrier and mouse
findings described above, association was observed for a cluster of
SNPs located between exons 4 and 12 of USH2A, specifically with
low-frequency hearing (Table 4). The top-associated SNP
(rs10864237, minP= 6.9 × 10−5) explained 0.3% of variance in
low-frequency hearing thresholds (βSE= 0.13) representing a 1
dB HL difference between risk (TT genotype) and non-risk (CC
genotype) individuals. These analyses therefore extend our pre-
vious findings to encompass common variants in USH2A and
low-frequency hearing thresholds within the typical range.
Gene-environment interactions associate with language. We
then explored a hypothesis that USH2A modulates low-frequency
hearing thresholds through indirect modulatory effects on sub-
sequent auditory perception and language development. In this
model, common USH2A variants impact hearing but also exert
secondary impacts on speech and language development, pre-
sumably as a result of less effective higher-order auditory per-
ception. Specifically, we again assessed common variants in
USH2A for association to language outcomes in ALSPAC, but this
time included low-frequency hearing thresholds as an interaction
factor42. Association was now observed with early vocabulary
(rs7532570) (Table 4). Within this interactive model, rs7532570
had a p-value of 8.6 × 10−5 compared to P= 0.15 in the additive
model. When combined with the findings of the direct association
analyses, these data suggest that common variants in USH2A can
modify low-frequency hearing thresholds and that, when
thresholds are altered USH2A can, in turn, modulate the risk of
disrupted language development. This mirrors the relationship
observed between low-frequency hearing and vocalization in
Ush2a HT mice, suggesting a parallel modulatory gene-
environment (GxE) interaction in mice and together confirming
that auditory perception represents a building block for language
development.
Genetic variants in USH2A exert distinct effects. To gain a more
complete picture of USH2A variation, gene-based analyses were
performed using UK10K genome sequence data (N= 1646 indi-
viduals), enabling the combined consideration of rare and com-
mon variants across coding and non-coding regions within a
single test. This large sequence dataset allows the detection of
variants with expected frequency as low at 0.03%. Three variant
selection thresholds were considered (all variants (N= 7619), rare
variants (MAF ≤ 1%, N= 5424) common variants (MAF ≥ 5%,
N= 1335)) in relation to the same three language and two
Table 1 Clinically relevant mutations observed in the UK10K dataset.
Genome
Location (hg19)
SNP ID Ref Alt No. of
carriers
identified
QUAL score MAF (gnomAD) Functional effect DNA change Amino
acid change
chr1:215956104 rs111033264 A G 1 24.8 2.889E-07 Missense c.10561T > C p.Trp3521Arg
chr1:215963510 rs148660051 C T 4 247 0.000003829 Missense c.10073G > A p.Cys3358Tyr
chr1:216019240 rs397518041 C T 1 46.4 0.00001627 Stop-Gain c.8981G> A p.Trp2994*
chr1:216420436 rs80338903 C – 7 967 0.0006835 Frameshift c.2299delG p.Glu767Serfs
chr1:216497582 rs121912600 C A 1 171 0.00004079 Missense c.1256G > T p.Cys419Phe
Genome location is given in the format chr:variant position (hg19). QUAL score refers to PHRED quality score for sequence data at given base. Ref is the allele observed in the Human Reference sequence
(hg19). Alt is the alternative allele observed in the UK10K. All variants were observed in a heterozygous form. Minor Allele Frequency (MAF) is given for all samples in the gnomAD population database
(https://gnomad.broadinstitute.org/). DNA change refers to the position in the coding sequence for the gene. Amino acid change refers to the position altered in the protein.
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hearing measures described above. Results showed dichotomous
effects between variant frequency classes; association to hearing
measures was driven by common variants while DLD status was
marginally associated with rare variants (Table 4).
GxE effects implicate hearing-modulated language pathways.
To explore similar genetic effects at a genome-wide level, a GxE
interaction study (GWIs) was completed. These exploratory
analyses enabled the identification of common variants that
influence language through low-frequency hearing and,
additionally allowed the evaluation of genes implicated in hearing
within the model identified41. Taking direction from the GxE
analyses above, a linear regression model was employed with
early vocabulary as the dependent variable and low-frequency
hearing thresholds as an interaction term (Supplementary Fig. 2).
Eight SNPs reached genome-wide significance (P < 5 × 10−8),
while 450 SNPs across 139 HGNC transcripts were nominally
associated (P ≤ 10−5) (Supplementary Dataset 2). Pathway ana-
lyses did not indicate an enrichment of genes previously related to
hearing or language (Supplementary Table 2) but instead revealed
an enrichment of protein-binding factors involved in cell
Table 2 Quantitative measures of language, reading and cognition in carriers of USH2A compared to non-carriers in UK10K
dataset.
Measure Age Range of
scores
(carriers)
Mean
score
(carriers)
No. of
non-
carriers
Range of
scores (non-
carriers)
Mean
Score (non-
carriers)
SD
(non-
carriers)
5th
percentile
No carriers
below 5th
percentile
Vocabulary score 3 years 64–246 214.77 1601 0–246 232.42 24.81 186 2 of 13
Plurals score 3 years 0–12 10.33 1594 1–12 10.32 2.02 6 0 of 12
Past tense score 3 years 0–42 35.17 1584 0–42 34.23 9.43 13 1 of 12
Word combination score 3 years 0–26 18.15 1593 0–26 22.79 4.31 15 4 of 13
Reading score: WORD 7 years 14–45 27.71 1558 0–50 30.11 8.74 15 1 of 14
Spelling score 7 years 42064 6.93 1547 0–15 8.36 4.27 2 0 of 14
WOLD comprehension 8 years 41456 8.36 1557 2–14 7.76 1.9 5 0 of 14
Nonword Repetition 8 years 43377 7.07 1558 0–12 7.47 2.46 3 0 of 14
WISC—Verbal IQ 8 years 99–130 116 1551 54–155 112.02 16.73 86 0 of 14
WISC—Performance IQ 8 years 82–132 102.71 1550 46–145 103.56 16.87 76 0 of 14
WISC—Total IQ 8 years 90–132 111.29 1545 46–148 109.22 16.21 82 0 of 14
Air conduction Right average 0.5, 1, 2, 4 kHz 7 years 2.5 to 12.5 8.08 1241 −3.75 to 37.5 8.18 5.31 17.5 0 of 13
Air conduction Left average 0.5, 1, 2, 4 kHz 7 years 0 to 16.25 7.79 1241 −8.75 to 40 7.90 5.45 17.5 0 of 13
MinMid—minimum air conduction thresholds
across the left and right ears, averaged across 1,
2 and 4KHz
7 years −1.67 to 11.67 5.13 1263 −8.33 to 40 6.48 5.53 16.67 0 of 13
MinLow—minimum air conduction thresholds
across the left and right ears at 0.5KHz
7 years 5 to 15 11.15 1240 −10 to 35 9.96 5.81 20 0 of 13
Fifteen quantitative measures of language and hearing were compared between individuals carrying USH2A variants that have previously been reported as pathogenic and control UK10K individuals
without such variants.
Table 3 Discrete measures of educational support, neurodevelopmental disorders and hearing in carriers of USH2A compared to
non-carriers in UK10K dataset.
Measure Age measured No affected USH2A
carriers
Freq in USH2A
carriers
No. of affected non-
carriers
Freq in non-
carriers
Carer worried about child’s speech 3 years 2 of 13 0.15 120 of 1580 0.08
Child has learning difficulties requiring special
arrangements at school
7 years 0 of 14 0 55 of 1548 0.04
Child has speech problems requiring special
arrangements at school
7 years 0 of 14 0 13 of 1548 0.01
Child has hearing problems requiring special
arrangements at school
7 years 0 of 14 0 30 of 1548 0.02
Child has eyesight problems requiring special
arrangements at school
7 years 0 of 14 0 13 of 1548 0.01
Child has physical problems requiring special
arrangements at school
7 years 0 of 14 0 12 of 1548 0.01
Child has reading difficulties requiring special
arrangements at school
7 years 0 of 14 0 70 of 1548 0.05
Child has emotional/behavioural problems requiring
special arrangements at school
7 years 0 of 14 0 22 of 1548 0.01
Child stutters/stumbles when speaks 8 years 3 of 14 0.21 119 of 1560 0.08
DAWBA DSM-IV clinical diagnosis - Any ADHD
disorder
7 years 0 of 14 0 20 of 1569 0.01
Mother told child has dyslexia 9 years 1 of 12 0.08 71 of 1540 0.05
Mother told child has dyspraxia 9 years 0 of 11 0 29 of 1513 0.02
Mother told child has dyscalculia 9 years 0 of 11 0 8 of 1496 0.01
Hearing Impairment (AC thresholds greater than
20db HL at 1,2,4 kHz)
7 years 0 of 13 0 114 of 1492 0.08
OME/abnormal middle ear pressure (<−100
mm H2O)
7 years 5 of 14 0.36 422 of 1510 0.28
Fifteen binary measures of developmental difficulties were compared between individuals carrying USH2A variants that have previously been reported as pathogenic and control UK10K individuals
without such variants.
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adhesion and cellular movement (Table 5). Cellular components
of cell projections, lamellipodia and synapses were also over-
represented (Table 5). These genome-wide analyses therefore
implicate cell migration and connectivity as potential mechan-
isms for the underlying effect of auditory perception upon speech
and language development.
Discussion
Language development is a multifaceted trait that relies on
interactions between many sub-servant mechanisms each subject
to genetic, cognitive and environmental effects, including audi-
tory processing and hearing. In this study, we consider develop-
mental links between a specific candidate gene (USH2A), hearing,
auditory perception, communicative mouse vocalization and
human vocabulary. Together, our data provide evidence that
auditory perception represents a building block for commu-
nicative and language development. The identification of a
USH2A stop-gain variant in the discovery family was sub-
stantiated by behavioural investigation of heterozygous Ush2a
knockout mice (Ush2a+/−). In contrast to full knockouts, these
mice presented with a distinctive low-frequency hearing loss (p <
0.05 at 15 Hz), accompanied by impairments in complex sound
processing that was present even after variance due to hearing
loss was removed, and also altered ultrasonic vocalizations.
Population data corroborated the functional effects of USH2A in
audition and early language development; children in the UK10K
cohort39 who carried pathogenic variants had increased low-
frequency hearing thresholds (+1.2 dB HL at 500 Hz) and
showed reduced early vocabulary when compared to non-carriers.
In a cohort of typically developing individuals41, variants at the 5′
end of the gene were directly associated with increased low-
frequency hearing thresholds (minP= 6.9 × 10−5). Within an
interactive genetic model, individuals carrying risk variants in the
presence of altered low-frequency hearing thresholds were found
to have a smaller vocabulary than those who carried only one of
these risk factors in isolation (minP= 8.6 × 10−5). Together,
these data demonstrate that allelic variations in USH2A are
associated with altered low-level hearing thresholds that, in turn,
impact speech and language development through the modula-
tion of higher-order acoustic processing. As such, even a subtle
degradation in hearing and subsequent complex acoustic pro-
cessing (as seen in heterozygous Ush2a mice) could devel-
opmentally derail language processing in humans.
Our findings are consistent with emerging evidence that dif-
ferent variant types can associate with variable outcomes, forming
an “allelic hierarchy” of disease-causing and complex risk var-
iants, representing a shift from Mendelian genetic models43. We
extend this hypothesis by demonstrating a multifaceted allelic
hierarchy in which rare and common variants within the same
gene can form reciprocal influences upon gene functions under
different environmental influences. The finding that heterozygous
disruption of USH2A led to altered hearing thresholds in the low-
frequency ranges was unexpected, as complete loss of this gene
results in Type-II Usher Syndrome characterized by congenital
high-frequency hearing loss40. While one previous study sug-
gested that carrier individuals may experience slight hearing
disturbances44, heterozygotes are generally considered apheno-
typic and do not show obvious deficits in clinical hearing tests40.
Our findings provide a molecular explanation for this; hetero-
zygous gene disruptions are typified by subtle changes in the
processing of low-frequency sounds that may be incidental to
routine audiologic assessment. Such changes would not necessa-
rily be detected in a clinical setting where the focus would be on
Usher-related high-frequency hearing loss. Notably, we found
that the low-frequency thresholds of carrier individuals were
consistently (marginally) below those of non-carriers, though still
within typical range. While it is unlikely that such subtle changes
in hearing thresholds (1–2 dB) at these frequencies would directly
lead to language disorder, we propose that mild changes in low-
level hearing may exert a snow-ball effect that derails higher-
order communicative processing. This model is akin to that
described for persistent otitis media with effusion which, in itself,
does not cause language disorder but may represent a risk factor
when persistent45. Our findings are of clinical importance given
that heterozygous loss of the USH2A gene is relatively
common–we found that carriers of heterozygous pathogenic
variants constitute 0.85% of the UK10K cohort studied here. This
Table 4 Association analyses of variants across USH2A in relation to language and hearing outcomes.
ALSPAC SNP-BASED analysis Additive model Interaction
CHR SNP BP (hg19) A1 MinLow MinMid DLD NWR Vocab DLD NWR Vocab
1 rs682319 216,417,675 T 0.0274 0.0706 0.742 0.804 0.0930 0.850 0.0914 0.00056
1 rs11120747 216,438,500 G 0.0062 0.901 0.194 0.961 0.238 0.962 0.0454 0.436
1 rs2168924 216,440,105 A 0.963 0.0147 0.463 0.0537 0.349 0.525 0.0375 0.393
1 rs1159143 216,454,483 T 0.0033 0.115 0.319 0.720 0.538 0.789 0.822 0.0749
1 rs10864237 216,466,861 C 6.92E-05 0.00999 0.317 0.988 0.244 0.912 0.184 0.531
1 rs17651066 216,470,121 C 0.0795 0.0676 0.493 0.315 0.122 0.250 0.309 0.0022
1 rs7532570 216,504,269 G 0.407 0.410 0.848 0.835 0.150 0.813 0.266 8.60E-05
1 rs1606357 216,521,091 T 0.00022 0.0425 0.780 0.871 0.491 0.358 0.611 0.532
1 rs17657634 216,552,571 G 0.910 0.153 0.337 0.0317 0.728 0.590 0.917 0.227
1 rs4253963 216,592,003 T 0.0146 0.0689 0.734 0.617 0.160 0.301 0.688 0.383
1 rs10779261 216,595,306 C 0.0340 0.0534 0.863 0.825 0.676 0.283 0.582 0.885
1 rs12723493 216,605,071 A 0.0187 0.233 0.393 0.659 0.827 0.650 0.166 0.311
UK10K GENE-BASED analysis
Variant subset MinLow MinMid DLD NWR Vocab
All variants 0.061 0.089 0.092 0.162 0.669
Rare variants (MAF≤ 1%) 0.932 0.513 0.0094 0.313 0.282
Common variants (MAF≥ 5%) 0.025 0.0087 0.710 0.204 0.277
At the variant level, SNPs were directly associated with low-frequency hearing thresholds but not language outcomes within an additive model.
In contrast, in an interactive model, which considers interactions between variants and low-frequency hearing thresholds, association was observed with early language outcomes.
At the gene level, association to hearing measures was largely driven by common variants while association to language impairment was stronger with rare variants.
SNPs are shown for 5′ region of association only (chr1:216,438,500-216,521,091, hg19).
Bold values indicate that p-value was significant after a Bonferroni correction for multiple testing.
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figure aligns well with gnomAD European samples, of whom
1.1% are carriers46. Thus although behavioural effects are likely to
be subtle, and may exert indirect effects within a more complex
genetic model as indicated by our gene-environment analyses, the
fact that 1 in 100 worldwide may be at risk calls for universal
updates to screening protocols.
Beyond this, our study highlights a directionality of effects in
which genetically-mediated differences in hearing (directly or
indirectly) affect the neuronal development of central auditory
processing systems and consequently influence language acqui-
sition. These observations generate two distinct temporal models;
(1), the feedback model, in which altered auditory input directly
affects neuronal development leading to perceptual deficits that,
in turn, increase the risk of speech and language disorders, or (2),
the double-hit model, in which altered hearing thresholds com-
bine with existing genetic factors to moderate the risk of speech
and language disorders. Exploratory network analyses implicate
synaptic connections and cell growth as important processes in
hearing-mediated language pathways perhaps suggesting the
importance of feedback mechanisms. Importantly, the mouse
strains employed here (I129) have a homogeneous background
that lacks overt risk mutations. This combines with low Ush2a
brain-expression47 and a lack of reported neuronal anomalies in
Ush2a knockouts27 to further substantiate the hypothesis that
patterns of emergent cochlear output can be shaped by primary
stereocilia activity48,49. The feedback model fits with a recent
single-cell sequencing study, which showed that auditory input
during early life can shape gene expression patterns in spiral
ganglion neurons (the primary tract between the cochlea and
brainstem)49. Under this model, early variations in hearing
thresholds can have long-lasting and complex downstream
effects, presumably through the modification of central
mechanisms. The double-hit model aligns with emerging
knowledge from high-throughput genomic studies, which indi-
cate the existence of complex shared mechanisms between dis-
orders and further suggest that a “one-gene, one-disorder”
expectation represents a gross simplification of genetic mechan-
isms both in disease and typical development50,51. The exact
mechanisms by which low-frequency hearing may influence
language development remain unclear but given the findings
presented here, we propose that differences in auditory input can
alter perception of speech. When these occur at critical time-
points or are combined with other (as yet unidentified) risk
factors, we hypothesise that this may have repercussions for the
development of expressive language. The current study considers
only air conductance thresholds but future studies may consider
other aspects of hearing, for example through the addition of
conductive hearing tests or measures of auditory brain responses
and exploration of the effects of otitis media. Future investiga-
tions are needed to delineate the temporal effects reported here.
Such studies will allow us to distinguish between impaired input
at the synaptic interface between hair cells and the brain, versus
altered linguistic circuitry or feedback, as well as to investigate
genetic modifiers and define critical developmental windows for
these interactions. The current study directly advances our
understanding of the behavioural effects of changes in the USH2A
gene and indicates that different levels of disruption can target
different sound frequencies. Our mouse models further suggests
that Ush2a-mediated alterations of sound perception can lead to
behavioural deficits that extend to vocalization.
Methods
Discovery family. The discovery pedigree consisted of 12 members (Fig. 1). Eight
individuals and all descendants of individual I.1 (Fig. 1) were affected by expressive
language disorder characterized by acute auditory processing difficulties and speech
dysarthria. All descendants of individual I.1 were affected indicating an autosomal
dominant inheritance pattern. The family was ascertained through proband IV.1.
Language phenotype. The proband (IV.1) was born at full-term by normal
delivery following an uneventful pregnancy. There were no early developmental
concerns and all gross motor milestones were achieved. However, early language
milestones were delayed. First word was reported at 18 months and she was
referred to a speech and language therapist at 2 years of age. A diagnosis of Specific
Language Impairment (SLI) was given at age 4 years and 8 months. In this
assessment, she showed particular difficulties understanding abstract language and
linguistic concepts and often failed to follow conversations when no visual cues
were given. She had an extensive vocabulary but her language processing was slow
and she often showed difficulties finding the word she needed. She showed
grammatical difficulties such as sequencing errors, simplification of sentence
structure and errors with word structure. On the Children’s Communication
Checklist (CCC-2), she scored below the 15th percentile on all four language scales
(speech, syntax, semantics and coherence) but above this range in scales of inap-
propriate initiation (60th percentile), use of context (34th percentile), nonverbal
communication (42nd percentile) and interests (36th percentile). At a clinical
assessment at 58 months, she showed typical hand-eye coordination and perfor-
mance. She did not present with dysmorphic features and hearing assessments
were normal.
There were also concerns regarding the proband’s younger Sister’s (IV.2)
language development. Her first words appeared around the age of 2 years. Motor
development was normal. She had mild to moderate bilateral conductive hearing
impairment due to recurrent ear infection and grommets were inserted at the age of
3. Following this, hearing assessments were normal but her speech and language
difficulties continued and she was diagnosed as having a severe speech disorder in
particular with expressive language and dysfluency with very good receptive
language skills. The proband (IV.1) and her sister (IV.2) both attend special
language units.
The proband’s Mother (III.3), maternal Great-Uncle (II.2) and Grandfather
(II.1) indicate that the deficits observed in the proband are typical across all family
members. The Mother and maternal Great-Uncle have not had formal assessments
but both struggled at school requiring speech and language therapy and have
difficulties with expressive speech and processing. The similarities between their
early difficulties and that of the proband and her sister are striking. Assessment of
the Grandfather (II.1) at 62 years of age indicated poor performance across
cognitive tasks (verbal and nonverbal) with particular difficulties in tests of recall
memory, visual recognition, literacy, executive function and information
processing (all below tenth percentile). In contrast, verbal recognition, object
naming and auditory attention skills were within the expected range. Pure-tone
audiometry showed normal hearing thresholds but deficits were noted across all
three tests of central auditory processing (dichotic digits, frequency pattern and
duration pattern).
SNP genotyping. Seven members of the discovery family (five affected individuals,
II.1, II.2, III.3, IV.1 and IV.2, and two unaffected individuals, II.4, III.4, Fig. 1) were
genotyped on Illumina HumanOmniExpress-12v1 Beadchips (San Diego, CA,
USA; ~750,000 SNPs). SNPs were excluded if the gentrain (genotype clustering
quality) score was <0.5 or genotyping success rate was <95%. All individuals had a
genotype rate>95%. Genotype data were used to construct haplotype sharing
patterns across the pedigree and to call copy number variants (CNVs) as
described below.
Haplotype reconstruction. SNP genotype data from seven family members were
used to construct haplotype sharing patterns within the Merlin package52. These
data were employed to filter candidate variants from the whole-genome sequence
data as described below.
Copy number calling. CNVs were called by two separate algorithms; PennCNV53
and QuantiSNP54. All samples had a log R ratio (LRR) SD < 0.35, a B-allele fre-
quency (BAF) drift value <0.002 and a waviness factor between −0.04 and 0.04 in
PennCNV and an average LRR SD < 0.3 and BAF SD < 0.15 in QuantiSNP. Any
CNV that contained at least three consecutive SNPs, had a confidence value
(PennCNV) or log Bayes Factor (QuantiSNP) of >10 and was predicted by both
PennCNV and QuantiSNP, with a minimum intersection of 50% each way, was
considered to be of ‘high confidence’. The innermost boundaries of the two
algorithm calls were used. CNVs were excluded if they spanned the centromere or
telomeres.
Whole-genome sequencing. DNA from two members of the discovery family
(II.2 and IV.1, Fig. 1) were subject to whole-genome sequencing enabling the
identification of possibly pathogenic variants within shared chromosome regions
across the wider pedigree. Sequencing was performed as part of the Oxford
University-Illumina WGS500 collaboration (http://www.well.ox.ac.uk/wgs500)55.
This project includes whole-genome sequences for 156 samples from clinical cases
in whom standard genetic tests were negative or where no standard tests were
available55.
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Sequencing was completed on the Illumina HiSeq platform (Illumina Inc, San
Diego, CA, USA) with 100nt, paired-end runs. Alignment was performed against
the Human Reference genome (build 37d5, hg19) in Stampy56 and duplicate reads
removed using Picard (http://broadinstitute.github.io/picard/). Variant sites (Single
nucleotide variants and indels less than 50 bp) were called using Platypus (v0.1.8)57.
The mean depth across all mapped sites was 28.03 and the transtition-transversion
ratio across the two samples was 1.99.
Variants that were shared by the two family members and passed quality filters
with PHRED quality scores≥20 were identified within vcftools58 (N= 17,767,
Supplementary Dataset 1). These were subsequently filtered through a step-wise
procedure to include variants which fell within chromosome regions shared only
between affected family members (using haplotype reconstruction data from the
wider pedigree as described above) (remaining N= 3743, Supplementary
Dataset 1). Potential functional relevance of shared variants were annotated using
SnpEff (v3.2)59. Variants that conferred a coding change (frameshift, non-
synonymous, canonical splice-variant or stop/start-gain/loss) (remaining N= 1223,
Supplementary Dataset 1) and were not described (or had a minor allele frequency
of 0) in the 1000 Genomes Phase I (v2) data (Apr 2012)60 (remaining N= 36,
Supplementary Dataset 1) and dbSNP (build 147)61 (remaining N= 6,
Supplementary Dataset 1) were prioritized for follow-up. Variants and filter data
are shown in Supplementary Dataset 1. Candidate variants were validated by
Sanger sequencing using BigDye (v3.1) on a 3730XL DNA analyzer (Applied
Biosystems, California) using standard protocols. Chromatograms were visualized
within FinchTV (www.geospiza.com/finchtv).
Replication cohorts. Targeted analyses of the identified candidate gene (USH2A ±
10Kb - chr1:215786236-216606738, hg19) were performed in two large population
cohorts; the Avon Longitudinal Study of Parents and Children (ALSPAC, 7,141
children, 3,615M:3,526F)41,62 and the UK10K dataset (1646 individuals,
785M:861F)39. The ALSPAC population cohort offers a wide range of neurode-
velopmental phenotypes (including language, memory, hearing and neu-
ropsychiatric measures) from children born to 14541 mothers from Avon in
199141. In addition to phenotype data, ALSPAC also provides genotype data
(Illumina Human Hap 550-quad array) for 8365 children41 allowing SNP-based
association analyses. A subset of ALSPAC children (1867 individuals) had whole-
genome sequence data available as part of the UK10K project39 allowing gene-
based association analyses of rare and common variants across the candidate gene.
Both replication cohorts were filtered to include only individuals with available
phenotype data, of British ethnicity, born at more than 32 weeks gestation and a
birth weight >1500 g. Additional filters were applied for the analysis of common
variation in the ALSPAC cohort. These aimed to exclude children with overt
pathology that may confound language development, namely nonverbal IQ < 65
and hearing loss (hearing thresholds above 40dbL). After these filters, the ALPSAC
replication set included 7141 children (3615M:3526F) and the UK10K replication
set included 1681 individuals (806M:875F). The UK10K cohort included fourteen
children with heterozygous USH2A mutations (Table 2) allowing the consideration
of developmental profiles including measures of early language development, later
language and cognitive ability, hearing function and neurodevelopmental disorders
across carrier children (30 measures in total, Tables 2 and 3).
Analyses targeted three measures of language (early vocabulary, Nonword
repetition and Developmental Language Disorder (DLD)) and two measures of air
conductance (mid- and low- frequency hearing thresholds) as directed by
observations in the heterozygote knockout mice. Details of these measures are
provided below and the ALSPAC website contains details of every available
measure through a fully searchable data dictionary and variable search tool (http://
www.bristol.ac.uk/alspac/researchers/our-data/).
Early vocabulary (vocab). The vocabulary measure represents a sum of items that
children could use and/or understand, from a list of 123 words, at age 3 (ALSPAC
variable KG865). This measure was derived from a parental questionnaire. Data
were available for 6165 genotyped children from the ALSPAC cohort and 1614
children from the UK10K cohort. Scores across both datasets ranged from 0 (child
did not understand or use any of the 123 words) to 246 (child could use and
understand all of the 123 words) (mean= 229.8, SD= 29.4).
Nonword repetition (NWR). An adaptation of the Nonword memory test63 was
used to assess short-term memory (ALSPAC variable F8SL105). This measure has
been shown to provide an accurate biomarker of speech and language
difficulties64,65. The tests were completed in clinic and consisted of 12 nonsense
words of between 3 and 5 syllables which the child had to listen to and repeat. This
test was completed at 8 years of age and data were available for 5229 genotyped
children from the ALSPAC cohort and 1572 children from the UK10K cohort.
Scores across both datasets ranged from 0 to 12 (mean= 7.3, SD= 2.5).
DLD status (DLD). A binary measure of DLD status was defined in line with our
previous publications65,66; cases performed at least 1 SD below mean on WOLD
comprehension (ALSPAC variable F8SL040) OR had CCC verbal fluency AND
syntax (ALSPAC variables KU503b and KU504b respectively) >1 SD below mean
with no evidence for Autistic Spectrum Disorder (ASD) or hearing impairment.
Typically developing controls were selected to perform above expected levels across
all of the three language measures used to define cases (WOLD comprehension,
CCC syntax and CCC verbal fluency) and had nonverbal IQ > 80 and presented
without neurodevelopmental disorders or special educational needs. The ALSPAC
cohort included 731 cases and 2114 controls and the UK10K cohort included 36
cases and 582 controls.
Mid-frequency hearing (MinMid). Audiometry was performed as per British
Society of Audiologists (BSA) standards—thresholds were taken as 2/3 presenta-
tions on the ascending scales. Both air- and bone-conduction were performed using
either a GSI 61 clinical audiometer or a Kamplex AD12 audiometer. All hearing
tests were carried out by audiologists and trained Staff in a room with minimal
external noise (not exceeding 35 dB). Minimum air conduction thresholds were
measured for the left and right ears at 0.5, 1, 2 and 4 kHz. Mid-range hearing was
defined as the minimum air conduction thresholds across the right and left ears
averaged across 1, 2 and 4 KHz (ALSPAC variables F7HS018 and F7HS028,
respectively). This measure was available for 4645 genotyped children from the
ALSPAC cohort and 1300 children from the UK10K cohort. Thresholds ranged
from −8.3 to +40 across these samples.
Low-frequency hearing (MinLow). Low-frequency hearing thresholds were
defined as the minimum air conduction thresholds across the left and right ears at
0.5KHz. This measure was derived from ALSPAC variables F7HS017, F7HS018,
F7HS027 and F7HS028). Data were available for 4563 genotyped children from the
ALSPAC cohort and 1277 children from the UK10K cohort. Thresholds ranged
from −10 to +40 across these samples.
Separate high-frequency threshold data were not available within the ALSPAC
data release for this project.
Gene-based association analyses. The UK10K cohort offered genome sequence
data, allowing characterization of developmental profiles in identified heterozygous
carriers. These sequence data were also employed for gene-based analyses of
common and rare variants within RVTESTS67. Gene-based testing employed
SKAT; a kernel-based method that allows for variants with different directions of
effects and can analyze both rare and common variants within a single model68. In
total, 7691 variants were analyzed. All variants had an allele count of at least 1 in
the sample set, affected only single nucleotides (i.e. SNVs), had a minimum mean
quality score of 20 and a minimum mean depth of 3 across samples and HWEp >
1 × 10−5. The transtition-transversion ratio of the SNVs was 2.2.
Association analyses of common variants. SNP data were available for ALSPAC
from Illumina 660 and Illumina 550 SNP arrays allowing allelic association ana-
lyses of common variants with the PLINK package42. Standard quality control
procedures69 were completed on genome-wide SNP data prior to analyses; variants
with a minor allele frequency <5%, a call rate of <5%, a Hardy-Weinberg equili-
brium p < 5 × 10−7 or a heterozygosity rate more than three standard deviations
from the mean were excluded. Per SNP genotype rates were compared between
DLD cases and controls and any SNP with a differential missing rate was excluded.
Individuals with a genotype rate <95%, discordant sex information or non-
Caucasian genetic background were excluded. Following quality control, SNPs
across the USH2A gene ±10Kb (chr1:215786236-216606738) were pruned using
the Tagger algorithm within Haploview70,71 to derive a pairwise tagging SNP set
with R2 < 0.8 consisting of 127 SNPs across 820Kb. Tagging SNPs were analyzed
for allelic association within PLINK42 using a linear model of regression for
quantitative traits and a logistic model for discrete traits.
Genetic interaction analyses. Gene-environment interaction effects were further
modeled within ALSPAC at the gene and genome-wide level using PLINK in which
the–interaction command can be used to model SNPxcovariate interactions within a
linear regression model (Y= b0+ b1.ADD+ b2.COV1+ b3.ADDxCOV1+ e)42.
Gene-level analyses were performed for 12 SNPs across the 5’ region of the USH2A
gene and comprised of three language outcome measures (Early vocabulary (vocab),
nonword repetition (NWR) and DLD status) and one interaction factor (Low-
frequency hearing threshold (MinLow)). At the genome level, a single outcome
measure (Early vocabulary (vocab)) was modelled with a single interaction factor
(Low-frequency hearing threshold (MinLow)) for 488205 autosomal SNPs. Man-
hattan plots were generated using the qqman package72 within R (v3.4.4) (https://
www.r-project.org/).
Pathway analyses. SNPs that had P values ≤ 10−5 in the genome-wide interaction
analyses (N= 450, Supplementary Dataset 2) were positioned within UCSC
(https://genome-euro.ucsc.edu/index.html, hg19) and those which mapped onto
known HGNC transcripts (N= 139, Supplementary Dataset 2) were entered into
pathway analyses to identify over-represented gene classes. Pathway analyses were
performed within STRING (https://string-db.org)73. Gene ontology classes were
analyzed for over-representations using a Fisher exact test with FDR multiple test
correction (Table 5). Identified genes were further compared to a list of 37 can-
didate genes for speech and language-related phenotypes (Taken from ref. 23 and
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supplemented with a list from refs. 23,74,75) and a list of 197 candidate genes for
hearing-related phenotypes (taken from http://hereditaryhearingloss.org/, supple-
mented with a list from the IMPC75) (Supplementary Table 2).
Ush2a mice—subjects. Six Ush2a knockout (KO) male mice27 were provided by
Dr. Jun Yang (University of Utah), and were re-derived on an 129S4/SvJaeJ
background strain at the Gene Targeting and Transgenic Facility (GTTF) at
UConn Health. All subjects were single housed in standard Plexiglass mouse-tubs
(12 h/12 h light-dark cycle), with food and water available ad libitum. F1 subjects
were delivered to the University of Connecticut where they were crossed with six
wild-type (WT) controls (129S4/SvJaeJ; stock number 009104) purchased from The
Jackson Laboratory (Bar Harbor, ME). The resulting F2 offspring were hetero-
zygous (HT) for the Ush2a gene, which shows 71% identity with its Human
orthologue. Breeding pairs (HT × HT) were used to generate the experimental
subjects, such that all genotypes (homozygous knockout, heterozygous, and wild-
type) were represented within-litter (F3). F3 genotypes were determined via PCR of
earpunch DNA using the following DNA primers: Common (5′-GTGAATACA
GGCACCTCTGAATGTGAC-3′), WT (5′-GTCACGGCTGAATCCCGAAGC-3′),
KO (5′-GAGATCAGCAGCCTCTGTTCCAC-3′). Twelve WT male mice, 12 HT
male mice, and 11 Ush2a KO male mice from F3 were randomly selected for
behavioural testing as outlined below (12 WT, 11 HT and 11 KO mice were used
when recording ultrasonic vocalizations).
Ush2a mice—auditory processing. Following puberty, subjects were tested on a
battery of auditory processing tasks using a modified prepulse inhibition paradigm
which allows free movement during the presentation of sounds that include an
unpredictable loud noise burst (see Fitch et al., 2008 for review)37. PPI provides a
superior index of acoustic processing at higher levels of the central auditory system
most relevant to receptive communication. In brief, PPI offers an index of stimulus
parameters that are behaviourally detectable, and while simple PPI is brainstem
and mid-brain mediated, the use of complex acoustic cues clearly engages auditory
cortex76. The engagement of cortical/behavioural thresholds is crucial to an
ethologically-relevant model of receptive communicative processing. The ability to
suppress an acoustic startle response (ASR; an involuntary, reflexive response to an
unexpected auditory stimulus [startle eliciting stimulus (SES); 105 dB, 50 ms,
broadband white noise burst (1–10 kHz)]) was measured. Subjects were placed on
cell-loaded platforms (Med Associates, St. Albans, VT), and presented with varying
auditory stimuli generated via RPvdsEx software and a RZ6 multifunction pro-
cessor (Tucker Davis Technologies, Alachua, FL). Subject motor reflex responses
were recorded via a Biopac MP150 acquisition system and Acqknowledge
4.1 software (Biopac Systems, Goleta, CA) connected to the load cell platforms.
Tasks are detailed below and included detection of simple tones (15 or 40 kHz) in
silence; and of deviant tones (variable duration) in a pure-frequency background
(Embedded Tone: 10.5 or 40 kHz background tone, 5.6 or 35 kHz cue tone; Pitch
Discrimination: 10.5 or 40.5 kHz tone ± 75 Hz or 8 kHz cue tone). Tone fre-
quencies were determined based on low and high-frequency bounds of the mouse
audiogram (~2–50 KHz)77. Testing began at postnatal (P) day 65 and continued to
P114. Normal Single Tone consisted of 104 trials conducted over one day, where
Embedded Tone and Pitch Discrimination each consisted of 300 trials and were
conducted over 5 consecutive days. During cued trials, subjects were presented with
an auditory cue (prepulse) 50 ms before the presentation of the SES (no cue pre-
sentation occurred during uncued trials). If the subject was able to detect the
auditory cue, an attenuation (or reduction) of their ASR was expected relative to
their ASR during an uncued trial. If the auditory cue was not detected, the response
was expected to equate to an uncued trial. Quantification of this phenomenon was
termed the “attenuation score” (ATT), which compared the mean amplitude of
cued ASR to that of the uncued ASR for each subject, for each session condition.
Mean cuedASR
Mean uncuedASR
´ 100
Normal single tone. Subjects were first tested on Normal Single Tone (NST) to
measure baseline prepulse inhibition, general auditory ability, and to rule out any
underlying auditory processing impairments that might impede performance on
subsequent auditory processing tasks (i.e. impaired reflex mechanics). Subjects
were required to detect a simple single tone (50 ms, 75 dB) against a silent back-
ground. This cue was presented 50 ms before the SES on half of the trials (104 cued
and uncued trials each, pseudorandom and evenly distributed), at inter-trial
intervals (ITI) ranging from 16 s–24 s. Two versions of this task were developed – a
15 kHz version (cue; 50 ms, 75 dB, 15,000 Hz tone) and a 40 kHz version (cue; 50
ms, 75 dB, 40,000 Hz tone). All subjects were able to perform both versions of the
task (15 kHz – P65; 40 kHz – P104). The frequency-matched NST score for each
subject was used as a covariate in the analysis of further tasks, specifically to
eliminate individual differences in PPI or hearing from subsequent auditory pro-
cessing analyses.
Embedded tone. The variable duration Embedded Tone Task (EBT) consisted of
300 pseudorandom trials with ITIs ranging from 16–24 s. Subject’s ability to detect
a change in tone frequency from a constant pure-tone background was measured,
and ATT scored were calculated. During cued trials, a single cue was presented 100
ms before the SES; for uncued trials, the “cue” was presented 0 ms before the SES
(i.e. no cue). Three versions of this task were used: (1) a long-duration EBT task,
where the cue duration ranged from 0ms to 100 ms (cue; 75 dB, 5600 Hz tone &
pure-tone background; 75 dB, 10,500 Hz tone); (2) a short-duration EBT task,
where the cue duration ranged from 0ms to 10 ms (cue; 75 dB, 5600 Hz tone and
pure-tone background; 75 dB, 10,500 Hz tone); (3) an ultrasonic long-duration
EBT task where the cue duration ranged from 0ms to 100 ms (cue; 75 dB, 35,000
Hz tone & pure-tone background; 75 dB, 40,000 Hz tone). This combination of
frequencies and temporal durations was designed to capture the range of proces-
sing capacities, allowing us to test for genotype-specific differences in that range.
Non-ultrasonic and ultrasonic versions of the task were necessary to determine any
Genotype effects observed were frequency dependent. Both non-ultrasonic versions
of the task were administered for five consecutive days, and the ultrasonic version
of the task was administered for four consecutive days (P67–P78; P103–106).
Pitch discrimination. Pitch Discrimination (PD) testing assessed the subject’s
ability to detect subtle changes in pitch within a constant pure-tone background.
Each testing session consisted of 300 pseudorandom trials, with an ITI ranging
from 16 s to 24 s. During cued trials, the cue was presented for 300 ms, 100 ms
before the SES. “Cues” presented during uncued trials were presented at the same
frequency as the pure-tone background. Two versions of this task were used for this
study: (1) PD task where the cue frequency deviated 5–75 Hz above or below a
10,500 Hz pure-tone background (cue: 300 ms, 75 dB tone and pure-tone back-
ground: 10,500 Hz tone); and (2) ultrasonic PD task where the cue frequency
deviated 5–75 Hz above or below a 40,500 Hz pure-tone background (cue: 300 ms,
75 dB tone & pure-tone background: 40,500 Hz tone). A non-ultrasonic PD task
was administered for five consecutive days, and an ultrasonic PD task was admi-
nistered for three consecutive days.
Ultrasonic vocalizations (USVs; P115–P120). Following assessment of auditory
processing ability, ultrasonic vocalizations (USVs) were recorded and analyzed
using methods adapted from Chabout et al.78. Using WT female homecage bedding
and urine collected 5 days prior to testing, a single experimental male mouse was
placed in a standard Plexiglass tub with a single novel WT female mouse and
allowed to freely interact for 5 min. In this setting, a male mouse will vocalize while
the female does not, such that recoded calls can be attributed to the male. A Brüel
& Kjær Type 4954-B microphone (Brüel & Kjær, Nærum, Denmark), connected to
a RME Fireface UC audio interface (RME Audio, Haimhausen, Germany), was
placed 5 cm above the top of the Plexiglass tub. USVs were recorded at 192,000 Hz
using DIGICheck 5.92 (RME Audio, Haimhausen, Germany) to ensure all USVs
were captured. Following USV recording, sound files (.wav) were analyzed in
MATLAB (MathWorks) using MUPET (Mouse Ultrasonic Profile ExTraction79).
Syllables in the range of 35,000 Hz to 110,000 Hz, and duration between 8 ms to
200 ms, were analyzed. If syllables occurred less than 5 ms apart, they were
excluded from analyses. Following these parameters, a syllable repertoire was
generated, illustrating 40 unique syllables (Supplementary Fig. 1). These 40 unique
syllables were then assigned to one of ten potential syllable groups, as defined by
Heckman et al.80. Eight syllable categories were created; Short, Down-FM, Up-FM,
Chevron, Flat, 1-Freq Step, Noisy, and Complex80. The mean frequency (kHz) of
each syllable was exported from MUPET and used for statistical analyses. Since
comparable Genotype effects were seen on all call types, only the mean frequency
shift is reported in the text (Fig. 3)—these USV frequency means collapse across all
eight call types.
Statistics and reproducibility (genomic analyses). The ALPSAC replication set
included 7141 children (3615M:3526F), providing 96% power to detect a variant
that explains 0.5% of the trait variance at a Bonferroni-corrected alpha level of
7.87 × 10−5. The final UK10K replication set included 1681 individuals
(806M:875F) providing 81% power to detect a variant that explains 1% of the trait
variance at a Bonferroni-corrected alpha level of 0.0033.
Gene-based analyses were performed within the UK10K dataset. These analyses
employed the SKAT test in RVTESTS67 and considered five traits (as detailed
above) using three SNP selection thresholds (all variants, rare variants (MAF ≤ 1%)
common variants (MAF ≥ 5%)), yielding a Bonferroni significance threshold of P
= 0.0033 at an alpha level of 0.05.
SNP-based analyses were performed within the ALSPAC dataset. These
analyses employed tests of allelic association within PLINK42 using a linear model
of regression for quantitative traits and a logistic model for discrete traits. Five
phenotypes were analyzed across 127 SNPs, yielding a Bonferroni significance
threshold of P= 7.87 × 10−5 at an alpha level of 0.05.
Gene-environment interaction effects were modeled within the ALSPAC dataset
at the gene and genome-wide level. These analyses used PLINK42, which employs a
linear regression model. Gene-level analyses were performed for 12 SNPs across the
5′ region of the USH2A gene and comprised of three language outcome measures
(Early vocabulary (vocab), nonword repetition (NWR) and DLD status) and one
interaction factor (Low-frequency hearing threshold (MinLow)) yielding a
Bonferroni significance threshold of P= 0.0014 at an alpha level of 0.05. At the
genome level, a single outcome measure (Early vocabulary (vocab)) was modelled
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with a single interaction factor (Low-frequency hearing threshold (MinLow)) for
488205 autosomal SNPs yielding a Bonferroni significance threshold of P= 1.02 ×
10−7 at an alpha level of 0.05.
Gene ontology classes were analyzed for over-representations using a Fisher
exact test with FDR multiple test correction.
Statistics and reproducibility (mouse analyses). Normal Single Tone attenua-
tion scores were analyzed using a one-way analysis of variance (ANOVA) com-
paring WT, HT, and Ush2a KO performance. To account for individual variation
in baseline prepulse inhibition and hearing, NST was used a covariate for sub-
sequent statistical analyses (NST 15 kHz was used as a covariate for all non-
ultrasonic auditory tasks; NST 40 kHz was used as a covariate for all ultrasonic
auditory tasks). EBT and PD tasks were analyzed using a mixed factorial design.
Differences in ATT scores for non-ultrasonic EBT 100 and EBT 10 were conducted
using a 3 × 5 × 9 repeated measures ANCOVA, with Genotype (three levels; WT,
HT, Ush2a KO) as the between-subjects variable, and Day (five levels) and cue
Duration (nine levels) as the within-subjects variables. Ultrasonic EBT 100 data
were analyzed using a 3 × 4 × 5 repeated measures ANCOVA with Genotype (three
levels) as the between-subjects variable, and Day (four levels) and cue Duration
(five levels) as the within-subjects variables. For Pitch Discrimination, a 3 × 5 × 9
and a 3 × 3 × 5 (for non-ultrasonic PD and ultrasonic PD, respectively) repeated
measures ANCOVA was used to determine ATT differences, where Genotype
(three levels) was the between-subject variables and Day (five levels, three levels)
and Frequency (nine levels, five levels) were the within-subject effects. Statistical
analyses were completed used SPSS 24 with an alpha criterion of 0.05.
For the analysis of ultrasonic vocalizations, the overall mean frequency
(collapsed across syllable category) was analyzed using a one-way analysis of
variance (ANOVA) comparing WT, HT and Ush2a KO scores (Fig. 3).
All animal behavioural testing were performed blind to genotype.
Ethics. Ethical approval for the discovery family was provided by University of
London & St George’s University Hospitals. All members provided informed
consent/assent of investigation. Ethical approval for ALSPAC was obtained from
the ALSPAC Ethics and Law Committee and the Local Research Ethics Commit-
tees (http://www.bristol.ac.uk/alspac/researchers/research-ethics/). All animal pro-
cedures conformed to the Guide for the Care and Use of Laboratory Animals and
were approved by the University of Connecticut Institute for Animal Care and Use
Committee (IACUC). The current animal study design adheres to the ARRIVE
guidelines81.
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
All shared variants found in the discovery family are provided in Supplementary Dataset 1.
ALSPAC and UK10K SNP and sequence data are available upon application as outlined at
http://www.bristol.ac.uk/alspac/researchers/access/. The ALSPAC website additionally
contains details of all the data that is available through a fully searchable data dictionary
and variable search tool (http://www.bristol.ac.uk/alspac/researchers/our-data/). Auditory
processing and USV data from murine behavioral testing are provided in Supplementary
Datasets 3 and 4, respectively.
Received: 1 November 2019; Accepted: 11 March 2020;
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